Clinical trial
Thrombocytes And IndividuaLization of ORal Antiplatelet Treatment After Percutaneous Coronary Intervention
NCT01135667 is registered in ClinicalTrials.gov with Lene Holmvang as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Thrombocytes And IndividuaLization of ORal Antiplatelet Treatment After Percutaneous Coronary Intervention
- Lead sponsor
- Lene Holmvang
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 30, 2010
- Completion date
- August 31, 2012
- Enrollment
- 106 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute coronary syndromes, coronary artery disease, percutaneous coronary intervention